Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Sunday, 20 September 2020, 13:13 HKT/SGT
Share:
Mitsubishi Chemical: Has developed new electrolyte for Tesla. The solvents and solute are supplied from Shida Shenghua

HONG KONG, Sept 20, 2020 - (ACN Newswire) - A Mitsubishi Chemical (MTLHY) technical expert revealed that the important innovations of Tesla's new battery are the positive and negative electrodes and the new electrolyte. Mitsubishi Chemical has perfectly matched the electrolyte technology for the new battery. This electrolyte mainly uses new solutes and functional additives, which can greatly improve battery performance. The technical expert said that the solvent in the new electrolyte is still supplied by the Chinese company Shida Shenghua, and the amount of DMC in the solvent will be greatly increased. Beginning in 2017, Mitsubishi and Shida Shenghua have jointly developed a new type of solute. This product will soon be mass-produced, which can effectively increase battery cycle times and energy density.



Topic: Press release summary Sectors: Daily Finance, Chemicals, Spec.Chem, Energy, Alternatives, Daily News
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Anime Tokyo Station: Celebrating the 25th Anniversaries of Two Popular Anime with an Anniversary Joint Exhibition Starting November 15  
Wednesday, December 3, 2025 10:30:00 AM
Polytek Engineering Selected as ORCA's Exclusive Distributor and Service Partner for Hong Kong  
Dec 3, 2025 07:00 HKT/SGT
Doubleview Provides Cobalt Resource Summary for the Hat Polymetallic Deposit in Advance of Updated MRE and PEA  
Dec 2, 2025 21:59 HKT/SGT
OpenAI Joins the Global Anti-Scam Alliance as Foundation Member to Strengthen Global Response Against AI-Enabled Scams  
Dec 2, 2025 21:00 HKT/SGT
Digital Realty and BW Digital Partner to Support Expansion of Cross-Border Connectivity Between Singapore and Batam  
Dec 2, 2025 15:49 HKT/SGT
GEN Announces New Positive Phase 1 Trial Data of the Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases  
Dec 2, 2025 13:00 HKT/SGT
AdipoLABs Opens New Regional Office, Signs Two MoUs With University of Cyberjaya to Advance Healthcare Innovation  
Dec 2, 2025 12:22 HKT/SGT
Fujitsu achieves high-precision, long-duration molecular dynamics simulation for all-solid-state battery interphases with over 100,000 atoms  
Monday, December 1, 2025 10:04:00 PM
Fujitsu develops multi-AI agent collaboration technology to optimize supply chains, launches joint trials  
Monday, December 1, 2025 9:43:00 PM
GMG Launches Pre-Order Sales for First to Market Multi Language THERMAL-XR(R) Kit with Electric Spray Gun  
Dec 1, 2025 21:29 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: